Results 241 to 250 of about 5,473 (299)

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat   +22 more
wiley   +1 more source

Investigating Synthetic Dolomite Mixtures and Phase Adjustment Parameters in Electrochemical Cement Precursor Production. [PDF]

open access: yesChemphyschem
Ramuglia AR   +11 more
europepmc   +1 more source

Amine-Functionalized Clays as Solid Sorbents: High-Pressure CO<sub>2</sub> Sorption Testing and Characterization. [PDF]

open access: yesACS Omega
Narváez J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy